Clinical trial
The Efficacy and Safety of Dexmedetomidine as an Additive to Ropivacaine for Interscalene Brachial Plexus Blocks for Shoulder Surgery
NCT01557270 is registered in ClinicalTrials.gov with Prof. Peter Gerner, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Dexmedetomidine as an Additive to Ropivacaine for Interscalene Brachial Plexus Blocks for Shoulder Surgery
- Lead sponsor
- Prof. Peter Gerner, M.D.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- November 30, 2012
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug safety, self efficacy